Bhattacharjee, M, Botting, C H, Sillanpää, M J · Genomics · 2008 · DOI
This study developed statistical methods to find biological markers (biomarkers) that could help identify and diagnose ME/CFS. The researchers used blood protein measurements and genetic information from ME/CFS patients to find which markers are most closely linked to the disease. Finding these biomarkers is important because ME/CFS is currently hard to diagnose and measure, and having reliable biological tests could change that.
ME/CFS lacks objective diagnostic biomarkers, making diagnosis challenging and delayed for many patients. Developing computational methods to systematically identify protein and genetic markers associated with ME/CFS could lead to diagnostic tests and better understanding of disease mechanisms. This study demonstrates a replicable statistical approach that could accelerate biomarker discovery in this understudied disease.
This methods paper does not establish which specific biomarkers are definitively associated with ME/CFS, as the abstract does not report the identified markers or their validation in independent cohorts. The study does not prove causation—identified biomarkers may be consequences of disease rather than contributing factors. Results require external validation and clinical utility assessment before application to patient diagnosis.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →